# Clinical Trial: THC/CBD Oil Significantly Reduced Use of Psychotropic Drugs in Patients &#8230;

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/clinical-trial-thc-cbd-oil-significantly-reduced-use-of-psychotropic-drugs-in-patients/
> **Published:** 2026-08-21T12:28:37-04:00 | **Last Modified / Clinically Audited:** 2026-09-08T20:15:58-04:00
> **Clinical Summary:** A clinical trial shows THC/CBD oil significantly reduces psychotropic drug use in dementia patients, offering a safer alternative for symptom management.

---

✦ New

CED Clinical Relevance
#67
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.

AgingMental HealthNeurologyCBDTHCResearchPolicy

Why This Matters
This clinical trial on THC/CBD oil significantly reducing psychotropic drug use in patients with dementia matters for clinicians and their patients as it presents a potential [alternative treatment](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) option. If proven effective, this could potentially minimize risks associated with psychotropic drugs for older adults with dementia, thereby improving [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and safety in clinical practice.

Clinical Summary

In a clinical trial, THC/CBD oil was found to significantly decrease the use of psychotropic drugs in patients with dementia. This reduction could potentially mitigate the substantial risks associated with these medications for older adults, offering a potential avenue for improved [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) in managing symptoms of dementia.

Dr. Caplan’s Take
“The recent [clinical trial findings](https://cedclinic.com/cannabidiol-sleep-wake-cycle-study-no-acute-effects/) suggest a promising potential for THC/CBD oil in managing psychotropic drug usage among elderly patients with dementia. However, as a family physician specializing in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), it’s crucial to emphasize that while these results are encouraging, further human-based research and peer review are necessary to fully understand the implications and ensure safe, effective treatment options for our patients.”

Clinical Perspective

💊 Emphasizing a potential clinical implication, the recent trial demonstrating THC/CBD oil’s effectiveness in decreasing psychotropic drug usage among dementia patients is noteworthy. While this finding offers promise for managing symptoms associated with dementia, it’s crucial to acknowledge the complexity of individual patient responses and potential confounders such as concurrent medications and disease severity. In practice, healthcare providers may consider exploring [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/) as a potential adjunctive strategy in the care of older adults with dementia, always ensuring careful monitoring for efficacy and adverse effects.

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Clinical%20Trial%3A%20THC%2FCBD%20Oil%20Significantly%20Reduced%20Use%20of%20Psychotropic%20Drugs%20in%20Patients%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74503)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74503)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Clinical%20Trial%3A%20THC%2FCBD%20Oil%20Significantly%20Reduced%20Use%20of%20Psychotropic%20Drugs%20in%20Patients%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74503)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

Related Articles

- [Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?](https://cedclinic.com/could-truly-water-soluble-cannabidiol-improve-oral-dosing/)

- [Cannabis and Blood Sugar Level: What the Research Actually Shows – View iLirknk9y](https://cedclinic.com/cannabis-and-blood-sugar-level-what-the-research-actually-shows-view-ilirknk9y/)

- [Cannabis-derived drug reduces nightmares in clinical trial: Study](https://cedclinic.com/cannabis-derived-drug-reduces-nightmares-in-clinical-trial-study/)

📰 Source: [https://themarijuanaherald.com/2026/08/thc-cbd-dementia/](https://themarijuanaherald.com/2026/08/thc-cbd-dementia/)

Further Reading
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

[Leave a Message](https://cedclinic.com/contact/)
[Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
[Medical Consulting](https://cedclinic.com/book/)
[Cannabis Care](https://cedclinic.com/book/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
